The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis
Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems.
For more information, please click on the following link:
https://www.rootsanalysis.com/....reports/single-use-u
The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis
Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance.
For additional details, please visit https://www.rootsanalysis.com/....reports/soft-tissue-
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.
For more information please click on the following link:
https://www.rootsanalysis.com/....reports/view_documen
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals.
For additional details, please visit
https://www.rootsanalysis.com/....reports/view_documen
The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis
Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.
For more information please click on the following link:
https://www.rootsanalysis.com/....reports/view_documen
